Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. | Mol Ther Nucleic Acids | 2022 | 35282417 | PubTator, text mining | PubMed |
| Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil. | BMJ Glob Health | 2022 | 35277426 | PubTator, text mining | PubMed |
| The Molecular Basis of FIX Deficiency in Hemophilia B. | Int J Mol Sci | 2022 | 35269902 | PubTator, text mining | PubMed |
| Current Advances in RNA Therapeutics for Human Diseases. | Int J Mol Sci | 2022 | 35269876 | PubTator, text mining | PubMed |
| Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation. | Int J Mol Sci | 2022 | 35269571 | PubTator, text mining | PubMed |
| Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress. | Cells | 2022 | 35269506 | PubTator, text mining | PubMed |
| Zinc finger protein ZPR1: promising survival motor neuron protein-dependent modifier for the rescue of spinal muscular atrophy. | Neural Regen Res | 2022 | 35259840 | PubTator, text mining | PubMed |
| Biochemical characterization of actin assembly mechanisms with ALS-associated profilin variants. | Eur J Cell Biol | 2022 | 35248815 | PubTator, text mining | PubMed |
| An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion. | Nat Commun | 2022 | 35241644 | PubTator, text mining | PubMed |
| Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus). | Neurologia (Engl Ed) | 2022 | 35241415 | PubTator, text mining | PubMed |
| CRISPR-Mediated Enzyme Fragment Complementation Assay for Quantification of the Stability of Splice Isoforms. | Chembiochem | 2022 | 35235240 | PubTator, text mining | PubMed |
| New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study. | Int J Neonatal Screen | 2022 | 35225937 | PubTator, text mining | PubMed |
| Evaluation of exonic copy numbers of SMN1 and SMN2 genes in SMA. | Gene | 2022 | 35219815 | PubTator, text mining | PubMed |
| Management of Spinal Muscular Atrophy in the Adult Population. | Muscle Nerve | 2022 | 35218574 | PubTator, text mining | PubMed |
| Oligonucleotide Therapeutics: From Discovery and Development to Patentability. | Pharmaceutics | 2022 | 35213992 | PubTator, text mining | PubMed |
| Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion. | Methods Mol Biol | 2022 | 35213009 | PubTator, text mining | PubMed |
| The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome. | Front Med (Lausanne) | 2022 | 35211492 | PubTator, text mining | PubMed |
| Insights into National Laboratory Newborn Screening and Future Prospects. | Medicina (Kaunas) | 2022 | 35208595 | PubTator, text mining | PubMed |
| The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Medicina (Kaunas) | 2022 | 35208537 | PubTator, text mining | PubMed |
| A Comprehensive Review of Neuromuscular Manifestations of COVID-19 and Management of Pre-Existing Neuromuscular Disorders in Children. | J Clin Med | 2022 | 35207206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=51